Dr S. P. Poonawalla is the Founder and CMD Of Cyrus Poonawalla Group headquartered in Pune that includes Serum Institute-India's top biotech company and world's largest vaccine manufacturer by number of doses-over 1.5 billion doses of vaccines for Measles, Polio and Flu annually. Forbes India in 2021 ranked him as the eighth richest Indian with a net worth of $18.9 billion. His business interests include Biotechnology, Finance, Aviation, Clean Energy, Hospitality and Real Estate. He is proactively involved in Corporate Social Responsibility.

HIS Contribution to Healthcare Landscape in India ;

* His continuous mission of global Immunisation saved hundreds of millions of underprivileged children across the globe.
* Fulfilled national shortage of vaccines and lifesaving drugs.
* In 1994 Serum Institute accredited by WHO to export vaccines to many UN
Agencies like UNICEF, PAHO (Pan American Health Organisation) etc.
* 1974-DTP Vaccine (Diphtheria, Tetanus, Pertussis).
* 1981-Anti Snake Venom.
* 1989-Measles Vaccine.
* By 2001,one out of every two children in the world received Serum India's vaccine.
* Assurance of the efficacy of another vaccine in case of unavailability of the second dose of the same vaccine of Covid 19.

Laurels Brought to Dr Cyrus S. Poonawalla ;

* Conferred Padma Shri by the Government of India in 2005.
* Conferred Padma Bhushan by the Government of India in 2022.
* Ernst & Young "Entrepreneur of the Year" Award in Healthcare and Life Sciences in 2007 and 2015.
* Honorary Doctorate by Universities of Massachusetts and Oxford in 2018 and 2019, respectively.
* Lokmanya Tilak National Award in 2021.
* First ever Vaccine Hero Award by the Global Alliance for Vaccine Initiative (GAVI).

Impact Brought in the Lives of Indians and to People Worldwide ;

It was Dr Poonawalla's path defining philanthropic initiatives, continuous mission of global immunisation and heavy investments to save maximum lives within the shortest possible time that Serum India's multiple Covid 19 partnerships launched CovieShield, the Vaccine developed by AstraZeneca and Oxford University that India could provide timely vaccine supply to the international community.